Do psychological attributes matter for adherence to antihypertensive medication the Finnish Public Sector Cohort Study

Journal of Hypertension

Volumn 26, Issue 11, 2008, Pages 2236-2243

  Nabi, Hermann ^a,b   Vahtera, Jussi ^c   Singh Manoux, Archana ^a,b,d   Pentti, Jaana ^c   Oksanen, Tuula ^c   Gimeno, David ^a   Elovainio, Marko ^a,e   Virtanen, Marianna ^c   Klaukka, Timo ^f   Kivimaki, Mika ^a,g  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d Versailles Saint Quentin en Yvelines University   (France)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f SOCIAL INSURANCE INSTITUTION   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hypertension; Medication adherence; Pharmacy refill records; Psychological factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; COMORBIDITY; FEMALE; FINLAND; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; MIDDLE AGED; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK; STATISTICS; TREATMENT REFUSAL;

ADULT; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; FEMALE; FINLAND; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT REFUSAL;

EID: 56049110838     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32830dfe5f     Document Type: Article

References (35)

1. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
2. De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2003; 2:323.
3. Burkhart PV, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003; 35:207.
4. Sabatâe E, World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
5. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J 2005; 149:785-794.
6. HillMN, Bone LR, Hilton SC, RoaryMC, KelenGD, Levine DM. A clinical trial to improve high blood pressure care in young urban black men: recruitment, follow-up, and outcomes. Am J Hypertens 1999; 12:548-554.
7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-497.
8. Schnall PL, Pieper C, Schwartz JE, Karasek RA, Schlussel Y, Devereux RB, et al. The relationship between 'job strain,' workplace diastolic blood pressure, and left ventricular mass index. Results of a case- control study. JAMA 1990; 263:1929-1935.
9. Spiro A 3rd, Aldwin CM, Ward KD, Mroczek DK. Personality and the incidence of hypertension among older men: longitudinal findings from the Normative Aging Study. Health Psychol 1995; 14:563-569.
10. Steptoe A, Cropley M. Persistent high job demands and reactivity to mental stress predict future ambulatory blood pressure. J Hypertens 2000; 18:581-586.
11. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99:2192-2217.
12. Wang PS, Bohn RL, Knight E,Glynn RJ,Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17:504-511.
13. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007; 120:26-32.
14. Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, Ismail SB, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens 2006; 20:23-29.
15. Lee D,Mendes de Leon CF, Jenkins CD, Croog SH, Levine S, Sudilovsky A.Relation of hostility to medication adherence, symptom complaints, and blood pressure reduction in a clinical eld trial of antihypertensive medication. J Psychosom Res 1992; 36:181-190.
16. Vahtera J, Kivimaki M, Pentti J, Linna A, Virtanen M, Virtanen P, Ferrie JE. Organisational downsizing, sickness absence, and mortality: 10-town prospective cohort study. BMJ 2004; 328:555.
17. Kivimaki M, Lawlor DA, Davey Smith G, Kouvonen A, Virtanen M, Elovainio M, Vahtera J. Socioeconomic position, co-occurrence of behavior-related risk factors, and coronary heart disease: the Finnish Public Sector study. Am J Public Health 2007; 97:874-879.
18. Antonovsky A. Unraveling themystery of health: how people manage stress and stay well. San Francisco: Jossey-Bass; 1987.
19. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism rom neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67:1063-1078.
20. Koskenvuo M, Kaprio J, Rose RJ, Kesaniemi A, Sarna S, Heikkila K, Langinvainio H. Hostility as a risk factor for mortality and ischemic heart disease in men. Psychosom Med 1988; 50:330-340.
21. Spielberger CD, Gorsuch RL. Manual for the State-Trait Anxiety Inventory (Form Y): ('self-evaluation questionnaire'). Palo Alto, CA: Consulting Psychologists Press, Inc; 1983.
22. Martikainen T, Pirinen E, Alhava E, Poikolainen E, Paakkonen M, Uusitupa M, Gylling H. Long-term results, late complications and quality of life in a series of adjustable gastric banding. Obes Surg 2004; 14:648-654.
23. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997; 50:619-625.
24. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general healthcare. Psychol Med 1997; 27:191-197.
25. Kouvonen A, Kivimaki M, Elovainio M, Vaananen AK, De Vogli R, Heponiemi T, Linna A, Pentti J, Vahtera J. Low organisational justice and heavy drinking: a prospective cohort study. Occup Environ Med 2007; 65:44-50.
26. Kujala UM, Kaprio J, Sarna S, Koskenvuo M. Relationship of leisure-time physical activity and mortality: the Finnish twin cohort. JAMA 1998; 279:440-444.
27. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997; 145:762-769.
28. Tsasis P. Adherence assessment to highly active antiretroviral therapy. AIDS Patient Care STDS 2001; 15:109-115.
29. Matsui D, Joubert GI, Dykxhoorn S, Rieder MJ. Compliance with prescription lling in the pediatric emergency department. Arch Pediatr Adolesc Med 2000; 154:195-198.
30. Cohen M, Kanter Y. Relation between sense of coherence and glycemic control in type 1 and type 2 diabetes. Behav Med 2004; 29:175-183.
31. Cederfjall C, Langius-Eklof A, Lidman K, Wredling R. Self-reported adherence to antiretroviral treatment and degree of sense of coherence in a group of HIV-infected patients. AIDS Patient Care STDS 2002; 16:609-616.
32. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med 1993; 36:725-733.
33. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19:1190-1196.
34. Kivimaki M, Feldt T, Vahtera J, Nurmi JE. Sense of coherence and health: evidence from two cross-lagged longitudinal samples. Soc Sci Med 2000; 50:583-597.
35. Williams AB. Adherence to HIV regimens: 10 vital lessons. Am J Nurs 2001; 101:37-43; quiz 44.